Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

4.79
+0.24005.27%
Post-market: 4.830.0385+0.80%19:54 EDT
Volume:2.22M
Turnover:10.54M
Market Cap:368.90M
PE:-3.58
High:4.89
Open:4.43
Low:4.37
Close:4.55
Loading ...
Mar 27, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 14, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report